Team members at the ³ûÖÊÓƵ Epilepsy Center conduct and participate in basic science and clinical research to evaluate new therapies for epilepsy.
Our team is proud to have played a significant role in developing and assessing most of the new anti-seizure medications available today. We continue to conduct clinical trials to develop new, better drugs.
Specialists at ³ûÖÊÓƵ Epilepsy Center have been crucial in developing:
- Vagal nerve stimulation (VNS), which is now an FDA-approved therapy
- Deep brain stimulation, a therapy approved for Parkinson's disease that is under study for epilepsy through the SANTE trial
How Our Research Helps ³ûÖÊÓƵ Patients
Patients whose epilepsy is not responding to standard treatments may participate in a clinical trial testing a new approach. Participation in a clinical trial is voluntary.
Patients enrolled in an investigational study at ³ûÖÊÓƵ Epilepsy Center receive:
- Careful medical supervision by a team of experts
- Trial medication at no cost to the patient
- Free comprehensive care (laboratory tests and studies, EEG and MRI in some cases, and doctors' visits)
- Compensation for travel